Koers Bellicum Pharmaceuticals, Inc. OTC Markets
Aandelen
BLCM
US0794814048
Biotechnologie & Medisch Onderzoek
Omzet 2021 | 6,2 mln. 5,81 mln. | Omzet 2022 | 1,5 mln. 1,41 mln. | Marktkapitalisatie | 824K 772K |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -9 mln. -8,44 mln. | Nettowinst (verlies) 2022 | -25 mln. -23,43 mln. | EV/omzet 2021 * | - |
Nettoliquiditeiten 2021 * | - 0 | Nettoliquiditeiten 2022 * | - 0 | EV/omzet 2022 * | - |
K/w-verhouding 2021 * |
-
| K/w-verhouding 2022 * |
-
| Werknemers | 13 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 * |
-
| Vrij verhandelbaar | 98,45% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,74% | 102 mld. | |
+2,27% | 96,07 mld. | |
-1,75% | 21,66 mld. | |
-17,53% | 20,77 mld. | |
-7,10% | 18,53 mld. | |
-40,31% | 16,91 mld. | |
-28,23% | 13,79 mld. | |
+0,15% | 13,33 mld. | |
+20,54% | 10,94 mld. |